PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas.

Mouse / Wound

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27109611 ↗2016Reported benefit

Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas.

MouseWoundC57BL/6Local administration to the cornea

Model: Corneal epithelial debridement wound in streptozotocin-induced type 1 diabetic mice

Local recombinant IL-1Ra partially but significantly reversed delayed re-epithelialisation and the associated cellular and neural changes in diabetic corneas; exogenous CXCL10 alleviated delayed healing in diabetic corneas but attenuated healing in normal corneas.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.